Clinical Trial: A Study to Assess the Effect of Itraconazole on the Pharmacokinetics of HRS-4642 Following Intravenous Infusion in Healthy Participants

U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906691) titled 'A Study to Assess the Effect of Itraconazole on the Pharmacokinetics of HRS-4642 Following Intravenous Infusion in Healthy Participants' on Oct. 25.

Brief Summary: HRS-4642-103 is a single-center, single-arm, open-label, fixed-sequence study to investigate the effect of Itraconazole on the pharmacokinetics of HRS-4642 following intravenous infusion in healthy participants.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Pancreatic Cancer

Intervention: DRUG: HRS4642

HRS4642.

DRUG: Itraconazole Capsules

Itraconazole capsules.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shanghai Hengrui Pharmaceutical ...